GET THE APP

Pharmaceutical Regulatory Affairs Open Access Articles | Open Access Journals

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Submit Manuscript

Pharmaceutical Regulatory Affairs Open Access Articles

The mission of the Pharmaceutical Regulatory Affairs: Open Access Journal provides a forum for publishing new findings on Pharmaceutical Regulatory Affairs. Currently, our primary research objective is to encourage and assist the development of better and faster measures of Pharmaceutical Regulatory Affairs activities. In cases where we believe we can contribute directly, as opposed to highlighting the work of others, we are producing our own measures of Pharmaceutical Regulatory Affairs research. Our work is mainly of interest to investors, organizations, and individuals in the financial sector and to significant corporations with global operations, as well as governments and academic researchers. Pharmaceutical Regulatory Affairs play a key role in knowledge societies and this knowledge is rising by leaps and bounds within no time. Scientists and academicians require a broad understanding of the latest updates in the respective discipline for their professional and learning endeavors. OMICS International with its open access journals represents the research findings and advancements in various scientific and medical disciplines.

High Impact List of Articles

Conference Proceedings

Some considerations about biosimilar safety
Samer M Al-Hulu
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Some considerations about biosimilar safety
Samer M Al-Hulu
Posters & Accepted Abstracts: Journal of Bioanalysis & Biomedicine
Insights into research on the anti-inflammatory and antinociceptive activities of Scandix iberica Bieb
Fatma Tugce Guragac, Mert Ilhan, Ibrahim Tumen and Esra Kupeli Akkol
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Insights into research on the anti-inflammatory and antinociceptive activities of Scandix iberica Bieb
Fatma Tugce Guragac, Mert Ilhan, Ibrahim Tumen and Esra Kupeli Akkol
Posters & Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Biosimilars market access and penetration in the Obama care era â�?�?Considerations for providers, payers, prescribers and patients
Gary C Cupit
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
Biosimilars market access and penetration in the Obama care era â�?�?Considerations for providers, payers, prescribers and patients
Gary C Cupit
Scientific Tracks Abstracts: Journal of Bioanalysis & Biomedicine
The relevance of safe final destination and rational prescription of drugs under regulatory issues with inclusion of environmental impact analysis on pharmacoeconomics studies
Nubia Regina de Oliveira
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
The relevance of safe final destination and rational prescription of drugs under regulatory issues with inclusion of environmental impact analysis on pharmacoeconomics studies
Nubia Regina de Oliveira
Accepted Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Problems encountered by third world countries especially Pakistan in pharmaceutical regulatory affairs and their remedies
Shoaib Ahmed
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access
Problems encountered by third world countries especially Pakistan in pharmaceutical regulatory affairs and their remedies
Shoaib Ahmed
Scientific Tracks Abstracts: Pharmaceutical Regulatory Affairs: Open Access

Relevant Topics in Pharmaceutical Sciences

Awards & Nominations

50+ Million Readerbase

Journal Highlights

Google Scholar citation report

Citations: 533

Pharmaceutical Regulatory Affairs: Open Access received 533 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

Related Links

Open Access Journals